| NAME | ORIGINATOR | INDICATION | DEVELOPMENT STATUS |
| REAGILA® | Gedeon Richter | Schizophrenia | Approved in EU Launch phase |
| methadone | Treatment of cancer-related pain in cases of resistance or intolerance to opioids | Filed in France | |
| CARBAGLU® | Recordati | Hyperammonaemia due to NAGS deficiency and to the main organic acidemias | Development of new formulations in EU and USA Pre-filing in the USA for the organic acidemias indication |
| REC 0551 | Recordati/Meyer Hospital (Florence) | Retinopathy of Prematurity (ROP) | Phase II |
| LYNOVEX® | NovaBiotics | Acute infectious exacerbations associated with cystic fibrosis | Phase II |
| REC 0438 | Recordati/UFPeptides | Neurogenic detrusor overactivity in paediatric spina bifida patients |
Proof of concept trial planning in EU |
| REC 0559 | Recordati/Mime Tech | Neurotrophic keratitis | Formulation development Clinical development planning |
| REC 0545 | Recordati/AP-HP | Acute decompensation episodes in MSUD | Formulation development Clinical development planning |